Novel hybrid biomimetic macroporous composites with tuned biodegradability, improved osteointegration and anticancer properties for bone tissue regeneration (HyBioComBone) Abstract

Main Article Content

Đorđe Veljović
https://orcid.org/0000-0001-6370-7167
Đorđe Janaćković
Rada Petrović
https://orcid.org/0000-0001-9511-5633
Biljana Ljujić
Milena Radunović
https://orcid.org/0000-0003-3507-1186
Anđela Radisavljević
Željko Radovanović
Vukašin Ugrinović
Tamara Matić
https://orcid.org/0000-0002-7415-0453
Marija Milivojević
Miloš Papić
https://orcid.org/0000-0001-7970-4892
Tamara Vlajić-Tovilović
Irena Ognjanović
Ivica Vujičić
https://orcid.org/0000-0003-2379-9022

Abstract

The treatment of large bone defects (LBDs) represents a major challenge in clinical orthopedics. Patients with LBDs caused by trauma, infections, or tissue resections due to cancer, often undergo multiple surgeries with long recovery times leading to deteriorated life quality and increased healthcare costs. The project HyBioComBone aims to develop novel biomimetic macroporous composites with multifunctional properties for bone repair, regeneration, and cancer treatment.

Article Details

Section

Biomaterials for orthopedic and dental applications

How to Cite

[1]
Đorđe . Veljović, “Novel hybrid biomimetic macroporous composites with tuned biodegradability, improved osteointegration and anticancer properties for bone tissue regeneration (HyBioComBone): Abstract”, Hem Ind, vol. 78, no. 1S, p. 51, Mar. 2024, Accessed: Dec. 22, 2024. [Online]. Available: https://www.ache-pub.org.rs/index.php/HemInd/article/view/1297

Funding data

References

-

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>